awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28534382-5BE6229E-D414-40B4-8F6A-0E67751A9617
Q28534382-5BE6229E-D414-40B4-8F6A-0E67751A9617
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534382-5BE6229E-D414-40B4-8F6A-0E67751A9617
Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer
P2860
Q28534382-5BE6229E-D414-40B4-8F6A-0E67751A9617
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534382-5BE6229E-D414-40B4-8F6A-0E67751A9617
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8192ad20dc9fc2633628f21f032e8c33517f1d28
P2860
Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer.